MSD’s monoclonal antibody, indicated for 15 types of cancer, smashed industry records with sales of $27.3 billion in 2024, with six years of monopoly remaining
A study highlights the unprecedented prices of a treatment for a rare and serious inherited disease
An Italian foundation that helped a young boy overcome Wiskott-Aldrich syndrome becomes the first non-profit in the world to request approval of these innovative treatments from the European Medicines Agency and the FDA
The researcher, a global liver damage expert, sounds the alarm over our limited awareness of the connection between drug consumption and rising death rates
A ‘bubble girl’ from Córdoba is cured of the disease thanks to an innovative treatment rescued by an Italian foundation when it was about to disappear due to its low profitability
A report by the OECD reveals that most national authorities want more international transparency when it comes to the purchase of drugs, but also that they refuse to report what they pay
The sweets have been linked to three deaths in America and at least one hospitalization in Germany
Researchers from the universities of Zurich, Yale and Harvard reveal the differences between the characteristics of the patients who receive the drug during pharmaceutical testing and those who end up receiving it, which may reduce its safety and efficacy
A British study into a food-borne pathogen outbreak linked to heavy rains highlights the risk climate change poses to public health
The president of Medicines for Europe considers that the supply of essential drugs is at risk if governments do not allow the price of cheap drugs to be revised in line with inflation
Lenacapavir, an antiviral drug already approved as a treatment that costs $40,000 in the US, prevented 100% of infections in a study on African women with just two injections a year. UNAIDS is asking the drugmaker Gilead to reduce the cost in order to make it more widely available
The arrival on the market of many innovative treatments has been hampered by pharmaceutical companies’ business strategies
Taking a single dose of doxycycline within 72 hours following high-risk contact can eliminate more than 80% of cases of two of the most common sexually transmitted infections
A center in Córdoba is leading a European study to determine the incidence of the disease, transmitted by rodents and the first diagnosis of which occurred in 2018 in Hong Kong
Emblaveo has been developed by Pfizer and AbbVie, with the help of the EU and the United States, and is effective against some multidrug-resistant infections that have been untreatable until now
Analysis shows a high viral load in the raw milk of infected animals. How the pathogen is spreading between cows remains unclear
The emeritus professor of genomics has managed to revive microorganisms that had been dormant for 48,500 years in the frozen soil of the Arctic
The European Medicines Agency is considering approving the first drug that has been shown to delay the onset of symptoms
The lack of research is a recognized problem in clinical guidelines, which are used in daily practice
The researcher, who revolutionized the discipline by describing new types of autoimmune encephalitis, is researching the consequences that these processes leave in the body
Many countries in the Americas and tourist hotspots like Thailand are battling the mosquito-borne diseases
A legislative reform being prepared by the European Union plans to promote the use of already approved drugs to treat other illnesses. Doing so will speed up the approval of treatments and save on research costs
Frequency of injections, the body’s immune response and errors in the administration of the drug can shorten the amount of time a patient will enjoy their desired results
The United Kingdom has introduced restrictions for non-immunized children in Birmingham, while Romania has declared a national epidemic after three deaths were reported
Health authorities are encouraging countries to strengthen surveillance systems and to report any changes in the incidence or severity of detected cases
The commercial strategy of the pharmaceutical company Bluebird Bio, which left the EU after a dispute with Germany over the price of another drug, leaves dozens of minors suffering from a rare fatal hereditary disease with no treatment
The minutes of a meeting of the Advisory Forum of the European Centre for Disease Prevention and Control reveal how eradicating the virus was ruled out as being too costly and counterproductive
